9.3 Glossary
- From Chapter 28
- basal insulin dosing
- an important component in diabetes management because it acts as a background insulin that is designed to stabilize blood glucose levels during times of fasting
- bolus
- a single dose of a drug being administered
- continuous glucose monitor
- a device that monitors blood glucose levels on a continual basis
- diabetes
- a disease that results from a deficiency in insulin that leads to alterations in the metabolism of glucose, fats, and proteins
- fasting blood glucose
- a test that measures the blood sugar level after an overnight fasting period
- glycosylated hemoglobin (A1c)
- a test that measures the blood sugar level over the past 60 to 90 days
- hyperglycemia
- a condition that occurs when the blood glucose level in the body is above the normal range of 70–110 mg/dL and the body has too little insulin or is insulin resistant, making it unable to lower the blood glucose level on its own
- hypoglycemia
- a condition that occurs when the blood glucose level in the body falls below the normal range of 70–110 mg/dL
- insulin
- a hormone released by β cells from the islets of Langerhans in the pancreas after eating a meal that helps the body’s cells absorb glucose for energy
- insulin pen
- a pen-shaped injector device that combines insulin and a syringe in one unit; insulin pens are prefilled with an insulin cartridge or have a prefilled insulin reservoir
- insulin pump
- a small, computerized infusion set device that delivers insulin
- ketoacidosis
- a life-threatening condition that occurs when the body breaks down fat too quickly, causing the liver to produce ketones, which in turn causes the blood to become acidic
- non-insulin injectable diabetes drugs
- drugs that provide an alternative to insulin therapy for those with type 2 diabetes; they act on hormones that are secreted along with insulin by the pancreas to control glucose homeostasis
- oral diabetes drugs
- drugs used to treat type 2 diabetes by lowering blood glucose levels
- peak time
- the time during which insulin is at its maximum strength in terms of lowering blood glucose levels; individuals are at a higher risk of developing hypoglycemic symptoms when insulin is peaking
- pheochromocytoma
- a rare non-cancerous tumor that develops in the adrenal gland that causes an excessive release of adrenal hormones
- polydipsia
- increased thirst
- polyphagia
- increased hunger
- polyuria
- frequent urination
- random blood glucose
- a test that measures the blood sugar level at the time tested
- sliding scale coverage
- varying the dose of insulin based on the blood glucose level
- subcutaneous
- situated or applied under the skin
- titrated
- continuously measuring and adjusting the balance of a drug dosage
- type 1 diabetes
- an autoimmune disorder in which the body’s immune system attacks and destroys the β cells in the pancreas that make insulin, resulting in elevated blood glucose levels
- type 2 diabetes
- a disorder that occurs as a result of the body not making enough insulin or not using insulin well
From Chapter 27
- antithyroid drugs
- inhibit the thyroid hormone so that the body can maintain normal thyroid homeostasis
- bisphosphonates
- pyrophosphate analogues that inhibit bone resorption and increase bone density
- calcimimetics
- drugs that mimic the action of calcium in the parathyroid glands or other tissues
- calcitonin
- a hormone secreted by the thyroid gland that lowers blood calcium
- Chvostek sign
- a twitch of the facial muscles that occurs with gentle tapping of the cheek and in front of the ear
- dihydroxyvitamin D3
- an active form of vitamin D3 that increases uptake of calcium absorption in the intestine
- endocrine glands
- glands within the endocrine system that release hormones to control processes that occur within the body
- goiter
- an abnormal enlargement of the thyroid gland
- Graves’ disease
- an immune disorder that results in the overproduction of thyroid hormones
- Hashimoto thyroiditis
- an autoimmune disorder that involves chronic inflammation of the thyroid gland, resulting in hypothyroidism
- iodine
- a mineral that the body needs to produce thyroid hormones
- iodotyrosine
- an iodo-derivative of tyrosine that acts as an intermediary in the biosynthesis of thyroid hormone
- myxedema coma
- a rare life-threatening condition caused by advanced hypothyroidism that affects the body’s temperature, growth, heart rate, and metabolism
- organification
- the biochemical process that takes place in the thyroid gland, involving the incorporation of iodine into thyroglobulin for the production of thyroid hormone
- osteoclast
- a large multinucleated cell responsible for the dissolution and absorption of bone
- osteonecrosis
- the death of bone tissue due to a lack of blood supply
- osteoporosis
- a condition that leads to the loss of bone mass, which thereby weakens bone
- Paget’s disease
- a disease that disrupts the body’s normal bone recycling process of replacing old bone tissue with new bone tissue
- parathyroid hormone (PTH)
- a peptide hormone secreted by the parathyroid glands that regulates serum calcium within the body
- thyroglobulin
- a protein present in the thyroid gland from which thyroid hormones are synthesized
- thyroid drugs
- drugs that replace the thyroid hormone so that the body can maintain its normal function
- thyroid gland
- a butterfly-shaped gland located in front of the neck below the voice box that is responsible for metabolism and iodine homeostasis within the body
- thyroid storm (thyrotoxic crisis)
- a rare life-threatening condition that occurs when the thyroid gland releases too much thyroid hormone
- thyroid-stimulating hormone (TSH)
- a hormone that stimulates the production of thyroxine and triiodothyronine; also known as thyrotropin
- thyroxine (T4)
- a hormone released by the thyroid gland that contains iodine and that increases the rate of chemical reactions within cells
- triiodothyronine (T3)
- a hormone released by the thyroid gland that plays a role in controlling the body’s metabolic rate, heart and digestive functions, muscle control, brain development and function, and bone maintenance
- Trousseau sign
- an involuntary contraction of the muscles in the hand and wrist
Next- Module 10
Access for free at https://openstax.org/books/pharmacology/pages/1-introduction
Barbour-Taylor, T., Mueller (Sabato), L., Paris, D., & Weaver, D. (2024). Pharmacology for Nurses. OpenStax.
by OpenStax is licensed under Creative Commons Attribution License v4.